CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,800 | $145.29 | $262K | 186,977 |
| 2024-11-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −100 | $146.35 | $15K | 186,877 |
| 2024-11-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,052 | $147.83 | $156K | 185,825 |
| 2024-11-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −351 | $148.92 | $52K | 185,474 |
| 2024-11-15 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −440 | $150.00 | $66K | 185,034 |
| 2024-11-14 | Marcus Gail Boxer Director | Sale | −500 | $156.75 | $78K | 21,098 |
| 2024-11-14 | Marcus Gail Boxer Director | Sale | −791 | $157.86 | $125K | 20,307 |
| 2024-11-14 | Marcus Gail Boxer Director | Sale | −350 | $159.19 | $56K | 19,957 |
| 2024-11-14 | Marcus Gail Boxer Director | Sale | −371 | $159.85 | $59K | 19,586 |
| 2024-11-14 | Marcus Gail Boxer Director | Sale | −200 | $162.04 | $32K | 19,386 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −8,026 | $152.69 | $1.2M | 271,746 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −11,974 | $154.11 | $1.8M | 259,772 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −4,011 | $152.78 | $613K | 51,921 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −64 | $153.51 | $10K | 51,857 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −4,075 | $160.02 | $652K | 47,782 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −3,617 | $152.93 | $553K | 52,315 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −458 | $154.40 | $71K | 51,857 |
| 2024-11-13 | Sheena Jonathan Director | Sale 10b5-1 | −4,075 | $160.02 | $652K | 47,782 |
| 2024-11-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion | +10,000 | $5.40 | $54K | 2,480,684 |
| 2024-11-12 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion · Stock Option (right to buy) | −10,000 | 68,496 |
Page 63 of 85 · 1,682 trades